Fourth industry stakeholder platform on the operation of the centralised procedure for human medicines

Date: 03/07/2017
Location: European Medicines Agency, London, UK
The objective of these platform meetings is to foster a constructive dialogue with industry stakeholders on operational matters of the centralised procedure and to identify opportunities for improvement. The focus of this fourth meeting is the outcome of the tripartite survey by rapporteurs, industry and the European Medicines Agency on initial marketing authorisation applications. Other topics include an exchange of experience with the new accelerated assessment process and the new linguistic review process, share experience with the use of the effects table to support benefit-risk discussions and to get industry feedback on some important updates in our post-authorisation procedures.

Documents

How useful was this page?

Add your rating